JP2005514335A - 腫瘍イメージング及び治療のためのｐａｃａｐ組成物及び方法 - Google Patents

腫瘍イメージング及び治療のためのｐａｃａｐ組成物及び方法 Download PDF

Info

Publication number
JP2005514335A
JP2005514335A JP2003535832A JP2003535832A JP2005514335A JP 2005514335 A JP2005514335 A JP 2005514335A JP 2003535832 A JP2003535832 A JP 2003535832A JP 2003535832 A JP2003535832 A JP 2003535832A JP 2005514335 A JP2005514335 A JP 2005514335A
Authority
JP
Japan
Prior art keywords
cancer
pacap
imaging
compound
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003535832A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005514335A5 (enExample
Inventor
マシュー エル．タクル マドフカル
Original Assignee
トマス ジェファソン ユニバーシティ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by トマス ジェファソン ユニバーシティ filed Critical トマス ジェファソン ユニバーシティ
Publication of JP2005514335A publication Critical patent/JP2005514335A/ja
Publication of JP2005514335A5 publication Critical patent/JP2005514335A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2003535832A 2001-10-19 2002-10-21 腫瘍イメージング及び治療のためのｐａｃａｐ組成物及び方法 Pending JP2005514335A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34451101P 2001-10-19 2001-10-19
PCT/US2002/033904 WO2003033030A1 (en) 2001-10-19 2002-10-21 Pacap compositions and methods for tumor imaging and therapy

Publications (2)

Publication Number Publication Date
JP2005514335A true JP2005514335A (ja) 2005-05-19
JP2005514335A5 JP2005514335A5 (enExample) 2006-02-02

Family

ID=23350835

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003535832A Pending JP2005514335A (ja) 2001-10-19 2002-10-21 腫瘍イメージング及び治療のためのｐａｃａｐ組成物及び方法

Country Status (9)

Country Link
US (1) US6855308B2 (enExample)
EP (1) EP1441773A1 (enExample)
JP (1) JP2005514335A (enExample)
KR (1) KR20040055784A (enExample)
CN (1) CN1571680A (enExample)
CA (1) CA2464002C (enExample)
IL (1) IL161332A0 (enExample)
RU (1) RU2004115104A (enExample)
WO (1) WO2003033030A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011013703A1 (ja) * 2009-07-31 2011-02-03 独立行政法人理化学研究所 膵臓内分泌細胞用指示薬、及びその利用
JP2016510342A (ja) * 2013-02-15 2016-04-07 トーマス・ジェファーソン・ユニバーシティＴｈｏｍａｓ Ｊｅｆｆｅｒｓｏｎ Ｕｎｉｖｅｒｓｉｔｙ 腫瘍画像化のためのキット
JP2016528299A (ja) * 2013-08-22 2016-09-15 ロバート・ドイルＲｏｂｅｒｔ ＤＯＹＬＥ ビタミンｂ１２および内因子を含む組成物およびその使用方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009739A1 (en) * 2002-02-14 2005-01-13 Wei Wang Formulation strategies in stabilizing peptides in organic solvents and in dried states
US9006181B2 (en) 2004-07-21 2015-04-14 The Administrators Of The Tulane Educational Fund Treatment of renal dysfunction and multiple myeloma using PACAP compounds
JP5908406B2 (ja) 2009-11-02 2016-04-26 ジ アドミニストレーターズ オブ ザ トゥレーン エデュケーショナル ファンド 下垂体アデニル酸シクラーゼ活性化ポリペプチド（ｐａｃａｐ）の類似体およびその使用方法
ES2667119T3 (es) * 2010-06-24 2018-05-09 Genomictree, Inc. Vector recombinante para suprimir la proliferación de células del papilomavirus humano que incluyen el gen del polipéptido activador de la adenilato ciclasa 1 (hipófisis) y composición farmacéutica para tratar el papilomavirus humano
KR20150143440A (ko) * 2013-02-15 2015-12-23 토마스 제퍼슨 유니버시티 떨어져 나가거나 순환 중인 종양세포를 생물학적 유액 내에서 탐지하는 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5997844A (en) * 1991-02-08 1999-12-07 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US6107459A (en) * 1991-02-08 2000-08-22 Diatide, Inc. Technetium-99m labeled peptides for diagnostic imaging
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US6165755A (en) * 1997-01-23 2000-12-26 University Of Victoria Innovation And Development Corporation Chicken neuropeptide gene useful for improved poultry production
US6395255B1 (en) * 1998-06-15 2002-05-28 Thomas Jefferson University Radiolabeled vasoactive intestinal peptide analogs for imaging and therapy

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011013703A1 (ja) * 2009-07-31 2011-02-03 独立行政法人理化学研究所 膵臓内分泌細胞用指示薬、及びその利用
JP5721106B2 (ja) * 2009-07-31 2015-05-20 国立研究開発法人理化学研究所 膵臓内分泌細胞用指示薬、及びその利用
JP2016510342A (ja) * 2013-02-15 2016-04-07 トーマス・ジェファーソン・ユニバーシティＴｈｏｍａｓ Ｊｅｆｆｅｒｓｏｎ Ｕｎｉｖｅｒｓｉｔｙ 腫瘍画像化のためのキット
JP2016528299A (ja) * 2013-08-22 2016-09-15 ロバート・ドイルＲｏｂｅｒｔ ＤＯＹＬＥ ビタミンｂ１２および内因子を含む組成物およびその使用方法

Also Published As

Publication number Publication date
EP1441773A1 (en) 2004-08-04
KR20040055784A (ko) 2004-06-26
CA2464002A1 (en) 2003-04-24
US20030129133A1 (en) 2003-07-10
WO2003033030A1 (en) 2003-04-24
CN1571680A (zh) 2005-01-26
CA2464002C (en) 2011-06-28
US6855308B2 (en) 2005-02-15
RU2004115104A (ru) 2005-02-20
IL161332A0 (en) 2004-09-27

Similar Documents

Publication Publication Date Title
JP7592120B2 (ja) 前立腺特異的膜抗原発現癌の診断または治療のための新規放射性金属結合化合物
JP7194161B2 (ja) 前立腺特異的膜抗原（ｐｓｍａ）の標識インヒビター、前立腺癌の治療のための画像化剤および薬剤としてのその使用
JP6562838B2 (ja) Ｇｒｐｒ陽性ガンの診断画像及び治療適用のための放射標識したｇｒｐｒアンタゴニスト
EP2862857A1 (en) Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
JPH08502075A (ja) 標識された単球走化性因子タンパク質材料およびその医学的使用
US20020155064A1 (en) Method for detection and localization of malignant human tumours
US12514938B2 (en) Fibroblast activation protein targeting peptides
RO120711B1 (ro) Reactivi de legare a receptorului de calcitonină şi variante marcate ale acestora
US6855308B2 (en) PACAP compositions and methods for tumor imaging and therapy
IL167518A (en) Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient
US6824759B2 (en) Radiolabeled vasoactive intestinal peptide analogs for imaging and therapy
US20040076581A1 (en) Use of neuropeptide y1 receptor binding compounds in the treatment and diagnosis of cancer
US20040185510A1 (en) Use of labelled CCK-B receptor ligands for the detection and localization of malignant human tumours
AU2002342104A1 (en) PACAP compositions and methods for tumor imaging and therapy
EP4640240A1 (en) Peptide-based radiopharmaceuticals for non-invasive imaging of the functional liver reserve
JP3866317B2 (ja) 金属キレート形成性ペプチド、その用途及びその製造方法
Volkert et al. 19. Development of Receptor-Avid Peptide 19. Developmen Radiotracers for Targeting e

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051021

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051021

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051206

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090120

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090721